title: Improvement of thyroid eye disease following treatment with the cyclooxygenase-2 selective inhibitor celecoxib.
authors.forename: Ajay E
authors.initials: AE
authors.lastname: Kuriyan
authors.forename: Richard P
authors.initials: RP
authors.lastname: Phipps
authors.forename: Charles W
authors.initials: CW
authors.lastname: O'Loughlin
authors.forename: Steven E
authors.initials: SE
authors.lastname: Feldon
mesh_terms: D000368:Aged; D000068579:Celecoxib; D003118:Color Perception / Q000187:drug effects; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D005260:Female; D049970:Graves Ophthalmopathy / Q000188:drug therapy*; D006801:Humans; D011241:Prednisone / Q000009:adverse effects; D011720:Pyrazoles / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D014792:Visual Acuity / Q000187:drug effects
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib; D011241:Prednisone